CEO Today Healthcare Awards

www.ceotodaymagazine.com CEO Today Healthcare Awards 2019 24 USA FIRM PROFILE RTI Surgical Holdings, Inc. is a leading global surgical implant company with a highly regarded portfolio of hardware, orthobiologic, tissue and synthetic implants distributed in nearly 50 countries. The company’s implants treat more than 600,000 patients annually, and are used in spine, orthopedic, sports medicine, general surgery, trauma and other surgical procedures. RTI has four manufacturing facilities throughout the United States and Europe and employs nearly 1,000 people globally. The company is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. RTI has made significant progress toward its vision of building a growing and sustainably profitable business that will treat more patients, offer growth opportunities for employees and create value for investors. To deliver on this vision, the company is reducing complexity, driving operational excellence and accelerating growth. RTI has made four divestitures over the past two years to focus the company on complementary spine and original equipment manufacturing (OEM) businesses to drive growth and predictable earnings. It also has initiated an aggressive cost reduction program and is more than halfway to achieving its goal of removing $25 million in costs by the end of 2019. As RTI has improved its processes and the predictability of its work, the company has increased its total revenue-to-employee headcount by nearly 30 percent since 2016. Progress in reducing complexity and driving operational excellence set the foundation to accelerate RTI’s growth both domestically and internationally. RTI’s spine business, which features a comprehensive portfolio of hardware and biologic options, has tripled in size over the past five years to become a top-10 spine company in the U.S. through: • External acquisitions, including Paradigm Spine (2019) and Zyga Technology (2018); • Partnership development, including securing ViBone ® as a next generation orthobiologic through a commercial partnership with Aziyo Biologics; and • Internal R&D, including the launches of the CervAlign TM Anterior Cervical Plate (ACP) System and Fortilink ® -C, -TS and -L Interbody Fusion (IBF) Systems with TETRAfuse ® 3D Technology, an award- winning product family recognized as a breakthrough technology. RTI’s OEM business offers design, development, regulatory and manufacturing capabilities in support of industry-leading medical technology companies serving the trauma, spine, dental and orthobiologics markets. Through its focus on customer intimacy, focused innovation and operational excellence, the OEM business provides predictable execution and cash flow for RTI. The RTI team is making great progress with a culture that embraces a passion for winning, continuous improvement, customer-centricity, collaboration and accountability. For more information, visit www.rtix.com and connect with RTI on LinkedIn and Twitter. ABOUT CAMILLE FARHAT Camille Farhat is a seasoned executive with a recognized track record of transforming, revitalizing and profitably growing businesses globally. Farhat is currently President and CEO of RTI Surgical Holdings, Inc. Since joining RTI in March 2017, Farhat has led a multi-year strategic transformation, generating solid operational and financial results and positioning the company for long-term, sustainable growth. Prior to joining RTI, Farhat was president and CEO of American Medical Systems (AMS), where he realigned the business to fund innovation, expand internationally and resume growth, ultimately leading to Boston Scientific’s $1.65 billion acquisition of the Men’s and Prostate Health businesses. Farhat has also held senior leadership roles at companies including Baxter Healthcare, Medtronic, Inc. and General Electric. Farhat serves on the board of directors of AdvaMed (the Advanced Medical Technology Association), Cardiac Science and CMR Surgical. He earned a Master of Business Administration from Harvard University, a degree in European Union Studies from Institut National d’Etudes Politiques de Paris and a bachelor’s degree in international finance and accounting from Northeastern University. CAMILLE FARHAT President & CEO of RTI Surgical